{"transactions":[{"id":2804332,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":141703,"kind":"person","name":"Nazzi Gianfranco","position":1,"cik":"0001725018","reported_name":"Nazzi Gianfranco","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, International Markets"}}],"security":"Restricted Share Units","published_at":"2021-03-08T21:08:34.000Z","date":"2021-03-04","kind":"exercise","acquired":false,"shares":12935,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Restricted share units were granted on March 4, 2019, with 12,935 vesting on each of March 4, 2021, March 4, 2022 and March 4, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Restricted share units were granted on March 4, 2019, with 12,935 vesting on each of March 4, 2021, March 4, 2022 and March 4, 2023."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":25870,"derivative":{"underlying":"Ordinary Shares","underlying_shares":12935},"source":{"system":"sec-edgar","filing":"0001209191-21-018524","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919121018524/doc4.xml","form_type":"4"}},{"id":2804331,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":141703,"kind":"person","name":"Nazzi Gianfranco","position":1,"cik":"0001725018","reported_name":"Nazzi Gianfranco","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, International Markets"}}],"security":"Ordinary Shares","published_at":"2021-03-08T21:08:34.000Z","date":"2021-03-04","kind":"sale","acquired":false,"shares":12935,"price":10.5844,"value":136909.214,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"kind","element":"transactionCoding","label":"F3","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.510 to $10.700, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-21-018524","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919121018524/doc4.xml","form_type":"4"}},{"id":2804330,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":141703,"kind":"person","name":"Nazzi Gianfranco","position":1,"cik":"0001725018","reported_name":"Nazzi Gianfranco","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, International Markets"}}],"security":"Ordinary Shares","published_at":"2021-03-08T21:08:34.000Z","date":"2021-03-04","kind":"grant","acquired":true,"shares":12935,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."}],"balance_after":12935,"source":{"system":"sec-edgar","filing":"0001209191-21-018524","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919121018524/doc4.xml","form_type":"4"}},{"id":2810199,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":141703,"kind":"person","name":"Nazzi Gianfranco","position":1,"cik":"0001725018","reported_name":"Nazzi Gianfranco","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, International Markets"}}],"security":"Restricted Share Units","published_at":"2021-03-04T21:04:03.000Z","date":"2021-03-03","kind":"exercise","acquired":false,"shares":1400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Restricted share units were granted on March 3, 2017, with 1,399 vesting on each of March 3, 2018, March 3, 2019 and March 3, 2020 and 1,400 vesting on March 3, 2021."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Restricted share units were granted on March 3, 2017, with 1,399 vesting on each of March 3, 2018, March 3, 2019 and March 3, 2020 and 1,400 vesting on March 3, 2021."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":1400},"source":{"system":"sec-edgar","filing":"0001209191-21-017761","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919121017761/doc4.xml","form_type":"4"}},{"id":2810198,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":141703,"kind":"person","name":"Nazzi Gianfranco","position":1,"cik":"0001725018","reported_name":"Nazzi Gianfranco","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, International Markets"}}],"security":"Ordinary Shares","published_at":"2021-03-04T21:04:03.000Z","date":"2021-03-03","kind":"sale","acquired":false,"shares":1400,"price":10.8796,"value":15231.44,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"kind","element":"transactionCoding","label":"F3","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.840 to $10.915, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-21-017761","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919121017761/doc4.xml","form_type":"4"}},{"id":2810197,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":141703,"kind":"person","name":"Nazzi Gianfranco","position":1,"cik":"0001725018","reported_name":"Nazzi Gianfranco","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, International Markets"}}],"security":"Ordinary Shares","published_at":"2021-03-04T21:04:03.000Z","date":"2021-03-03","kind":"exercise","acquired":true,"shares":1400,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."}],"balance_after":1400,"source":{"system":"sec-edgar","filing":"0001209191-21-017761","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919121017761/doc4.xml","form_type":"4"}},{"id":2823339,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":141703,"kind":"person","name":"Nazzi Gianfranco","position":1,"cik":"0001725018","reported_name":"Nazzi Gianfranco","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, International Markets"}}],"security":"Restricted Share Units","published_at":"2021-03-02T21:07:09.000Z","date":"2021-02-28","kind":"exercise","acquired":false,"shares":15177,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Restricted share units were granted on February 28, 2020 with 15,177 vesting on each of February 28, 2021, February 28, 2022 and February 28, 2023 and 15,180 vesting on February 28, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"Restricted share units were granted on February 28, 2020 with 15,177 vesting on each of February 28, 2021, February 28, 2022 and February 28, 2023 and 15,180 vesting on February 28, 2024."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":45534,"derivative":{"underlying":"Ordinary Shares","underlying_shares":15177},"source":{"system":"sec-edgar","filing":"0001209191-21-015847","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919121015847/doc4.xml","form_type":"4"}},{"id":2823338,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":141703,"kind":"person","name":"Nazzi Gianfranco","position":1,"cik":"0001725018","reported_name":"Nazzi Gianfranco","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, International Markets"}}],"security":"Ordinary Shares","published_at":"2021-03-02T21:07:09.000Z","date":"2021-03-01","kind":"sale","acquired":false,"shares":60410.357,"price":10.8796,"value":657240.5200172,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"kind","element":"transactionCoding","label":"F3","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.84 to $10.91, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-21-015847","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919121015847/doc4.xml","form_type":"4"}},{"id":2823337,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":141703,"kind":"person","name":"Nazzi Gianfranco","position":1,"cik":"0001725018","reported_name":"Nazzi Gianfranco","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, International Markets"}}],"security":"Ordinary Shares","published_at":"2021-03-02T21:07:09.000Z","date":"2021-03-01","kind":"sale","acquired":false,"shares":15177,"price":10.8509,"value":164684.1093,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"kind","element":"transactionCoding","label":"F3","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.775 to $11.005, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":60410.357,"source":{"system":"sec-edgar","filing":"0001209191-21-015847","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919121015847/doc4.xml","form_type":"4"}},{"id":2823336,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":141703,"kind":"person","name":"Nazzi Gianfranco","position":1,"cik":"0001725018","reported_name":"Nazzi Gianfranco","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, International Markets"}}],"security":"Ordinary Shares","published_at":"2021-03-02T21:07:09.000Z","date":"2021-02-28","kind":"exercise","acquired":true,"shares":15177,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."}],"balance_after":75587.357,"source":{"system":"sec-edgar","filing":"0001209191-21-015847","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919121015847/doc4.xml","form_type":"4"}},{"id":2867770,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":141703,"kind":"person","name":"Nazzi Gianfranco","position":1,"cik":"0001725018","reported_name":"Nazzi Gianfranco","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, International Markets"}}],"security":"Restricted Share Units","published_at":"2021-02-11T21:07:43.000Z","date":"2021-02-09","kind":"exercise","acquired":false,"shares":11941,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"Restricted share units were granted on February 9, 2018, with 11,941 vesting on each of February 9, 2020, February 9, 2021 and February 9, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F8","text":"Restricted share units were granted on February 9, 2018, with 11,941 vesting on each of February 9, 2020, February 9, 2021 and February 9, 2022."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":11941,"derivative":{"underlying":"Ordinary Shares","underlying_shares":11941},"source":{"system":"sec-edgar","filing":"0001209191-21-009637","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919121009637/doc4.xml","form_type":"4"}},{"id":2867769,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":141703,"kind":"person","name":"Nazzi Gianfranco","position":1,"cik":"0001725018","reported_name":"Nazzi Gianfranco","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, International Markets"}}],"security":"Ordinary Shares","published_at":"2021-02-11T21:07:43.000Z","date":"2021-02-09","kind":"sale","acquired":false,"shares":17480,"price":12.7209,"value":222361.332,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"kind","element":"transactionCoding","label":"F5","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"shares","element":"transactionShares","label":"F6","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the restricted share units listed in Table II."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.635 to $12.800, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":60410.357,"source":{"system":"sec-edgar","filing":"0001209191-21-009637","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919121009637/doc4.xml","form_type":"4"}},{"id":2867768,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":141703,"kind":"person","name":"Nazzi Gianfranco","position":1,"cik":"0001725018","reported_name":"Nazzi Gianfranco","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, International Markets"}}],"security":"Ordinary Shares","published_at":"2021-02-11T21:07:43.000Z","date":"2021-02-09","kind":"sale","acquired":false,"shares":4155,"price":12.7209,"value":52855.3395,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"kind","element":"transactionCoding","label":"F5","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"shares","element":"transactionShares","label":"F6","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the restricted share units listed in Table II."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.635 to $12.800, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":77890.357,"source":{"system":"sec-edgar","filing":"0001209191-21-009637","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919121009637/doc4.xml","form_type":"4"}},{"id":2867767,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":141703,"kind":"person","name":"Nazzi Gianfranco","position":1,"cik":"0001725018","reported_name":"Nazzi Gianfranco","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, International Markets"}}],"security":"Ordinary Shares","published_at":"2021-02-11T21:07:43.000Z","date":"2021-02-09","kind":"grant","acquired":true,"shares":50260,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents ordinary shares received upon satisfaction of performance- and time-based vesting criteria of performance share units."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Each performance share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources\nand Compensation Committee, the cash value of one ordinary share."}],"balance_after":82045.357,"source":{"system":"sec-edgar","filing":"0001209191-21-009637","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919121009637/doc4.xml","form_type":"4"}},{"id":2867766,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":141703,"kind":"person","name":"Nazzi Gianfranco","position":1,"cik":"0001725018","reported_name":"Nazzi Gianfranco","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, International Markets"}}],"security":"Ordinary Shares","published_at":"2021-02-11T21:07:43.000Z","date":"2021-02-09","kind":"exercise","acquired":true,"shares":11941,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."}],"balance_after":31785.357,"source":{"system":"sec-edgar","filing":"0001209191-21-009637","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919121009637/doc4.xml","form_type":"4"}},{"id":3201333,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":141703,"kind":"person","name":"Nazzi Gianfranco","position":1,"cik":"0001725018","reported_name":"Nazzi Gianfranco","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, International Markets"}}],"security":"Restricted Share Units","published_at":"2020-03-19T11:36:17.000Z","date":"2020-03-17","kind":"exercise","acquired":false,"shares":874,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Restricted share units were granted on March 17, 2016, with 872 vesting on each of March 17, 2018 and March 17, 2019 and 874 vesting on March 17, 2020."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"Restricted share units were granted on March 17, 2016, with 872 vesting on each of March 17, 2018 and March 17, 2019 and 874 vesting on March 17, 2020."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":874},"source":{"system":"sec-edgar","filing":"0001209191-20-020164","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919120020164/doc4.xml","form_type":"4"}},{"id":3201332,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":141703,"kind":"person","name":"Nazzi Gianfranco","position":1,"cik":"0001725018","reported_name":"Nazzi Gianfranco","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, International Markets"}}],"security":"Ordinary Shares","published_at":"2020-03-19T11:36:17.000Z","date":"2020-03-17","kind":"sale","acquired":false,"shares":345,"price":7.1714,"value":2474.133,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"kind","element":"transactionCoding","label":"F3","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"shares","element":"transactionShares","label":"F4","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the restricted share units listed in Table II."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.1600 to $7.2000, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":19844.357,"source":{"system":"sec-edgar","filing":"0001209191-20-020164","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919120020164/doc4.xml","form_type":"4"}},{"id":3201331,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":141703,"kind":"person","name":"Nazzi Gianfranco","position":1,"cik":"0001725018","reported_name":"Nazzi Gianfranco","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, International Markets"}}],"security":"Ordinary Shares","published_at":"2020-03-19T11:36:17.000Z","date":"2020-03-17","kind":"exercise","acquired":true,"shares":874,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."}],"balance_after":20189.357,"source":{"system":"sec-edgar","filing":"0001209191-20-020164","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919120020164/doc4.xml","form_type":"4"}},{"id":3225617,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":141703,"kind":"person","name":"Nazzi Gianfranco","position":1,"cik":"0001725018","reported_name":"Nazzi Gianfranco","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, International Markets"}}],"security":"Restricted Share Units","published_at":"2020-03-05T13:11:50.000Z","date":"2020-03-03","kind":"exercise","acquired":false,"shares":1399,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Restricted share units were granted on March 3, 2017, with 1,399 vesting on each of March 3, 2018, March 3, 2019 and March 3, 2020 and 1,400 vesting on March 3, 2021."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"Restricted share units were granted on March 3, 2017, with 1,399 vesting on each of March 3, 2018, March 3, 2019 and March 3, 2020 and 1,400 vesting on March 3, 2021."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":1400,"derivative":{"underlying":"Ordinary Shares","underlying_shares":1399},"source":{"system":"sec-edgar","filing":"0001209191-20-016460","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919120016460/doc4.xml","form_type":"4"}},{"id":3225616,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":141703,"kind":"person","name":"Nazzi Gianfranco","position":1,"cik":"0001725018","reported_name":"Nazzi Gianfranco","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, International Markets"}}],"security":"Ordinary Shares","published_at":"2020-03-05T13:11:50.000Z","date":"2020-03-03","kind":"sale","acquired":false,"shares":548,"price":11.7657,"value":6447.6036,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"kind","element":"transactionCoding","label":"F3","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"shares","element":"transactionShares","label":"F4","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the restricted share units listed in Table II."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.7300 to $11.8100, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":19315.357,"source":{"system":"sec-edgar","filing":"0001209191-20-016460","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919120016460/doc4.xml","form_type":"4"}},{"id":3225615,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":141703,"kind":"person","name":"Nazzi Gianfranco","position":1,"cik":"0001725018","reported_name":"Nazzi Gianfranco","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, International Markets"}}],"security":"Ordinary Shares","published_at":"2020-03-05T13:11:50.000Z","date":"2020-03-03","kind":"exercise","acquired":true,"shares":1399,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."}],"balance_after":19863.357,"source":{"system":"sec-edgar","filing":"0001209191-20-016460","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919120016460/doc4.xml","form_type":"4"}},{"id":3235428,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":141703,"kind":"person","name":"Nazzi Gianfranco","position":1,"cik":"0001725018","reported_name":"Nazzi Gianfranco","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, International Markets"}}],"security":"Restricted Share Units","published_at":"2020-03-03T12:16:36.000Z","date":"2020-02-28","kind":"grant","acquired":true,"shares":60711,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Restricted share units were granted on February 28, 2020 with 15,177 vesting on each of February 28, 2021, February 28, 2022 and February 28, 2023 and 15,180 vesting on February 28, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Restricted share units were granted on February 28, 2020 with 15,177 vesting on each of February 28, 2021, February 28, 2022 and February 28, 2023 and 15,180 vesting on February 28, 2024."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F3","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":60711,"derivative":{"underlying":"Ordinary Shares","underlying_shares":60711},"source":{"system":"sec-edgar","filing":"0001209191-20-014852","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919120014852/doc4.xml","form_type":"4"}},{"id":3280650,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":141703,"kind":"person","name":"Nazzi Gianfranco","position":1,"cik":"0001725018","reported_name":"Nazzi Gianfranco","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Growth Markets Commercial"}}],"security":"Restricted Share Units","published_at":"2020-02-11T12:01:35.000Z","date":"2020-02-09","kind":"exercise","acquired":false,"shares":11941,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Restricted share units were granted on February 9, 2018, with 11,941 vesting on each of February 9, 2020, February 9, 2021 and February 9, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"Restricted share units were granted on February 9, 2018, with 11,941 vesting on each of February 9, 2020, February 9, 2021 and February 9, 2022."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":23882,"derivative":{"underlying":"Ordinary Shares","underlying_shares":11941},"source":{"system":"sec-edgar","filing":"0001209191-20-008165","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919120008165/doc4.xml","form_type":"4"}},{"id":3280649,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":141703,"kind":"person","name":"Nazzi Gianfranco","position":1,"cik":"0001725018","reported_name":"Nazzi Gianfranco","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Growth Markets Commercial"}}],"security":"Ordinary Shares","published_at":"2020-02-11T12:01:35.000Z","date":"2020-02-10","kind":"sale","acquired":false,"shares":4155,"price":12.2417,"value":50864.2635,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"kind","element":"transactionCoding","label":"F3","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"shares","element":"transactionShares","label":"F4","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the restricted share units listed in Table II."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.2400 to $12.2450, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":18464.357,"source":{"system":"sec-edgar","filing":"0001209191-20-008165","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919120008165/doc4.xml","form_type":"4"}},{"id":3280648,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":141703,"kind":"person","name":"Nazzi Gianfranco","position":1,"cik":"0001725018","reported_name":"Nazzi Gianfranco","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Growth Markets Commercial"}}],"security":"Ordinary Shares","published_at":"2020-02-11T12:01:35.000Z","date":"2020-02-09","kind":"exercise","acquired":true,"shares":11941,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."}],"balance_after":22619.357,"source":{"system":"sec-edgar","filing":"0001209191-20-008165","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919120008165/doc4.xml","form_type":"4"}},{"id":3409356,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":141703,"kind":"person","name":"Nazzi Gianfranco","position":1,"cik":"0001725018","reported_name":"Nazzi Gianfranco","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Growth Markets Commercial"}}],"security":"Restricted Share Units","published_at":"2019-09-20T11:19:09.000Z","date":"2019-09-18","kind":"exercise","acquired":false,"shares":2638,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Restricted share units were granted on September 18, 2017, with 2,638 vesting on each of September 18, 2018 and September 18, 2019."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Restricted share units were granted on September 18, 2017, with 2,638 vesting on each of September 18, 2018 and September 18, 2019."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":2638},"source":{"system":"sec-edgar","filing":"0001209191-19-050265","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919119050265/doc4.xml","form_type":"4"}},{"id":3409355,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":141703,"kind":"person","name":"Nazzi Gianfranco","position":1,"cik":"0001725018","reported_name":"Nazzi Gianfranco","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Growth Markets Commercial"}}],"security":"Ordinary Shares","published_at":"2019-09-20T11:19:09.000Z","date":"2019-09-18","kind":"sale","acquired":false,"shares":962,"price":7.8203,"value":7523.1286,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"shares","element":"transactionShares","label":"F3","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the restricted share units listed in Table II."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.81 to $7.84, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":10678.357,"source":{"system":"sec-edgar","filing":"0001209191-19-050265","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919119050265/doc4.xml","form_type":"4"}},{"id":3409354,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":141703,"kind":"person","name":"Nazzi Gianfranco","position":1,"cik":"0001725018","reported_name":"Nazzi Gianfranco","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Growth Markets Commercial"}}],"security":"Ordinary Shares","published_at":"2019-09-20T11:19:09.000Z","date":"2019-09-18","kind":"exercise","acquired":true,"shares":2638,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."}],"balance_after":11640.357,"source":{"system":"sec-edgar","filing":"0001209191-19-050265","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919119050265/doc4.xml","form_type":"4"}},{"id":3589277,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":141703,"kind":"person","name":"Nazzi Gianfranco","position":1,"cik":"0001725018","reported_name":"Nazzi Gianfranco","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Growth Markets Commercial"}}],"security":"Restricted Share Units","published_at":"2019-03-19T12:17:26.000Z","date":"2019-03-17","kind":"exercise","acquired":false,"shares":872,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Restricted share units were granted on March 17, 2016, with 872 vesting on each of March 17, 2018 and March 17, 2019 and 874 vesting on March 17, 2020."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Restricted share units were granted on March 17, 2016, with 872 vesting on each of March 17, 2018 and March 17, 2019 and 874 vesting on March 17, 2020."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":874,"derivative":{"underlying":"Ordinary Shares","underlying_shares":872},"source":{"system":"sec-edgar","filing":"0001209191-19-020162","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919119020162/doc4.xml","form_type":"4"}},{"id":3589276,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":141703,"kind":"person","name":"Nazzi Gianfranco","position":1,"cik":"0001725018","reported_name":"Nazzi Gianfranco","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Growth Markets Commercial"}}],"security":"Ordinary Shares","published_at":"2019-03-19T12:17:26.000Z","date":"2019-03-18","kind":"sale","acquired":false,"shares":320,"price":16.6446,"value":5326.272,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"shares","element":"transactionShares","label":"F3","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the restricted share units listed in Table II."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $ 16.6400 to $16.6516, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":9002.357,"source":{"system":"sec-edgar","filing":"0001209191-19-020162","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919119020162/doc4.xml","form_type":"4"}},{"id":3589275,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":141703,"kind":"person","name":"Nazzi Gianfranco","position":1,"cik":"0001725018","reported_name":"Nazzi Gianfranco","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Growth Markets Commercial"}}],"security":"Ordinary Shares","published_at":"2019-03-19T12:17:26.000Z","date":"2019-03-17","kind":"exercise","acquired":true,"shares":872,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."}],"balance_after":9322.357,"source":{"system":"sec-edgar","filing":"0001209191-19-020162","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919119020162/doc4.xml","form_type":"4"}},{"id":3596256,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":141703,"kind":"person","name":"Nazzi Gianfranco","position":1,"cik":"0001725018","reported_name":"Nazzi Gianfranco","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Growth Markets Commercial"}}],"security":"Restricted Share Units","published_at":"2019-03-14T11:36:17.000Z","date":"2019-03-12","kind":"exercise","acquired":false,"shares":883,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Restricted share units were granted on March 12, 2015, with 880 vesting on March 12, 2018 and 883 vesting on March 12, 2019."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Restricted share units were granted on March 12, 2015, with 880 vesting on March 12, 2018 and 883 vesting on March 12, 2019."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":883},"source":{"system":"sec-edgar","filing":"0001209191-19-019330","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919119019330/doc4.xml","form_type":"4"}},{"id":3596255,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":141703,"kind":"person","name":"Nazzi Gianfranco","position":1,"cik":"0001725018","reported_name":"Nazzi Gianfranco","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Growth Markets Commercial"}}],"security":"Ordinary Shares","published_at":"2019-03-14T11:36:17.000Z","date":"2019-03-12","kind":"sale","acquired":false,"shares":325,"price":15.6898,"value":5099.185,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"shares","element":"transactionShares","label":"F3","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the restricted share units listed in Table II."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.670 to $15.705, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":8450.357,"source":{"system":"sec-edgar","filing":"0001209191-19-019330","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919119019330/doc4.xml","form_type":"4"}},{"id":3596254,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":141703,"kind":"person","name":"Nazzi Gianfranco","position":1,"cik":"0001725018","reported_name":"Nazzi Gianfranco","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Growth Markets Commercial"}}],"security":"Ordinary Shares","published_at":"2019-03-14T11:36:17.000Z","date":"2019-03-12","kind":"exercise","acquired":true,"shares":883,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."}],"balance_after":8775.357,"source":{"system":"sec-edgar","filing":"0001209191-19-019330","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919119019330/doc4.xml","form_type":"4"}},{"id":3609964,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":141703,"kind":"person","name":"Nazzi Gianfranco","position":1,"cik":"0001725018","reported_name":"Nazzi Gianfranco","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Growth Markets Commercial"}}],"security":"Restricted Share Units","published_at":"2019-03-06T12:20:30.000Z","date":"2019-03-04","kind":"grant","acquired":true,"shares":38805,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Restricted share units were granted on March 4, 2019, with 12,935 vesting on each of March 4, 2021, March 4, 2022 and March 4, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Restricted share units were granted on March 4, 2019, with 12,935 vesting on each of March 4, 2021, March 4, 2022 and March 4, 2023."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F3","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":38805,"derivative":{"underlying":"Ordinary Shares","underlying_shares":38805},"source":{"system":"sec-edgar","filing":"0001209191-19-017233","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919119017233/doc4.xml","form_type":"4"}},{"id":3616196,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":141703,"kind":"person","name":"Nazzi Gianfranco","position":1,"cik":"0001725018","reported_name":"Nazzi Gianfranco","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Growth Markets Commercial"}}],"security":"Restricted Share Units","published_at":"2019-03-05T13:20:45.000Z","date":"2019-03-03","kind":"exercise","acquired":false,"shares":1399,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Restricted share units were granted on March 3, 2017, with 1,399 vesting on each of March 3, 2018, March 3, 2019 and March 3, 2020 and 1,400 vesting on March 3, 2021."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Restricted share units were granted on March 3, 2017, with 1,399 vesting on each of March 3, 2018, March 3, 2019 and March 3, 2020 and 1,400 vesting on March 3, 2021."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":2799,"derivative":{"underlying":"Ordinary Shares","underlying_shares":1399},"source":{"system":"sec-edgar","filing":"0001209191-19-016097","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919119016097/doc4.xml","form_type":"4"}},{"id":3616195,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":141703,"kind":"person","name":"Nazzi Gianfranco","position":1,"cik":"0001725018","reported_name":"Nazzi Gianfranco","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Growth Markets Commercial"}}],"security":"Ordinary Shares","published_at":"2019-03-05T13:20:45.000Z","date":"2019-03-04","kind":"sale","acquired":false,"shares":512,"price":16.8844,"value":8644.8128,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"shares","element":"transactionShares","label":"F3","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the restricted share units listed in Table II."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.755 to $17.1316, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":7892.357,"source":{"system":"sec-edgar","filing":"0001209191-19-016097","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919119016097/doc4.xml","form_type":"4"}},{"id":3616194,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":141703,"kind":"person","name":"Nazzi Gianfranco","position":1,"cik":"0001725018","reported_name":"Nazzi Gianfranco","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Growth Markets Commercial"}}],"security":"Ordinary Shares","published_at":"2019-03-05T13:20:45.000Z","date":"2019-03-03","kind":"exercise","acquired":true,"shares":1399,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."}],"balance_after":8404.357,"source":{"system":"sec-edgar","filing":"0001209191-19-016097","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919119016097/doc4.xml","form_type":"4"}},{"id":3811105,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":141703,"kind":"person","name":"Nazzi Gianfranco","position":1,"cik":"0001725018","reported_name":"Nazzi Gianfranco","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Growth Markets Commercial"}}],"security":"Restricted Share Units","published_at":"2018-09-20T20:09:23.000Z","date":"2018-09-18","kind":"exercise","acquired":false,"shares":2638,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Restricted share units were granted on September 18, 2017, with 2,638 vesting on each of September 18, 2018 and September 18, 2019."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Restricted share units were granted on September 18, 2017, with 2,638 vesting on each of September 18, 2018 and September 18, 2019."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":2638,"derivative":{"underlying":"Ordinary Shares","underlying_shares":2638},"source":{"system":"sec-edgar","filing":"0001209191-18-051778","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919118051778/doc4.xml","form_type":"4"}},{"id":3811104,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":141703,"kind":"person","name":"Nazzi Gianfranco","position":1,"cik":"0001725018","reported_name":"Nazzi Gianfranco","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Growth Markets Commercial"}}],"security":"Ordinary Shares","published_at":"2018-09-20T20:09:23.000Z","date":"2018-09-18","kind":"sale","acquired":false,"shares":1379,"price":23.691,"value":32669.889,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the restricted share units listed in Table II."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.680 to $23.720, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":7005.357,"source":{"system":"sec-edgar","filing":"0001209191-18-051778","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919118051778/doc4.xml","form_type":"4"}},{"id":3811103,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":141703,"kind":"person","name":"Nazzi Gianfranco","position":1,"cik":"0001725018","reported_name":"Nazzi Gianfranco","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Growth Markets Commercial"}}],"security":"Ordinary Shares","published_at":"2018-09-20T20:09:23.000Z","date":"2018-09-18","kind":"exercise","acquired":true,"shares":2638,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."}],"balance_after":8384.357,"source":{"system":"sec-edgar","filing":"0001209191-18-051778","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919118051778/doc4.xml","form_type":"4"}},{"id":3988470,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":141703,"kind":"person","name":"Nazzi Gianfranco","position":1,"cik":"0001725018","reported_name":"Nazzi Gianfranco","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Growth Markets Commercial"}}],"security":"Restricted Share Units","published_at":"2018-03-20T20:11:47.000Z","date":"2018-03-17","kind":"exercise","acquired":false,"shares":872,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Restricted share units were granted on March 17, 2016, with 872 vesting on each of March 17, 2018 and March 17, 2019 and 874 vesting on March 17, 2020."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Restricted share units were granted on March 17, 2016, with 872 vesting on each of March 17, 2018 and March 17, 2019 and 874 vesting on March 17, 2020."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":1746,"derivative":{"underlying":"Ordinary Shares","underlying_shares":872},"source":{"system":"sec-edgar","filing":"0001209191-18-020862","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919118020862/doc4.xml","form_type":"4"}},{"id":3988469,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":141703,"kind":"person","name":"Nazzi Gianfranco","position":1,"cik":"0001725018","reported_name":"Nazzi Gianfranco","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Growth Markets Commercial"}}],"security":"Ordinary Shares","published_at":"2018-03-20T20:11:47.000Z","date":"2018-03-19","kind":"sale","acquired":false,"shares":457,"price":17.892,"value":8176.644,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the restricted share units listed in Table II."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.87 to $17.92, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":5746.357,"source":{"system":"sec-edgar","filing":"0001209191-18-020862","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919118020862/doc4.xml","form_type":"4"}},{"id":3988468,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":141703,"kind":"person","name":"Nazzi Gianfranco","position":1,"cik":"0001725018","reported_name":"Nazzi Gianfranco","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Growth Markets Commercial"}}],"security":"Ordinary Shares","published_at":"2018-03-20T20:11:47.000Z","date":"2018-03-17","kind":"exercise","acquired":true,"shares":872,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."}],"balance_after":6203.357,"source":{"system":"sec-edgar","filing":"0001209191-18-020862","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919118020862/doc4.xml","form_type":"4"}},{"id":3997149,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":141703,"kind":"person","name":"Nazzi Gianfranco","position":1,"cik":"0001725018","reported_name":"Nazzi Gianfranco","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Growth Markets Commercial"}}],"security":"Restricted Share Units","published_at":"2018-03-14T20:31:21.000Z","date":"2018-03-12","kind":"exercise","acquired":false,"shares":880,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Restricted share units were granted on March 12, 2015, with 880 vesting on March 12, 2018 and 883 vesting on March 12, 2019."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Restricted share units were granted on March 12, 2015, with 880 vesting on March 12, 2018 and 883 vesting on March 12, 2019."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":883,"derivative":{"underlying":"Ordinary Shares","underlying_shares":880},"source":{"system":"sec-edgar","filing":"0001209191-18-019565","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919118019565/doc4.xml","form_type":"4"}},{"id":3997148,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":141703,"kind":"person","name":"Nazzi Gianfranco","position":1,"cik":"0001725018","reported_name":"Nazzi Gianfranco","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Growth Markets Commercial"}}],"security":"Ordinary Shares","published_at":"2018-03-14T20:31:21.000Z","date":"2018-03-12","kind":"sale","acquired":false,"shares":461,"price":19.498,"value":8988.578,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the restricted share units listed in Table II."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.49 to $19.5107, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":5331.357,"source":{"system":"sec-edgar","filing":"0001209191-18-019565","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919118019565/doc4.xml","form_type":"4"}},{"id":3997147,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":141703,"kind":"person","name":"Nazzi Gianfranco","position":1,"cik":"0001725018","reported_name":"Nazzi Gianfranco","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Growth Markets Commercial"}}],"security":"Ordinary Shares","published_at":"2018-03-14T20:31:21.000Z","date":"2018-03-12","kind":"exercise","acquired":true,"shares":880,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."}],"balance_after":5792.357,"source":{"system":"sec-edgar","filing":"0001209191-18-019565","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919118019565/doc4.xml","form_type":"4"}},{"id":4012722,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":141703,"kind":"person","name":"Nazzi Gianfranco","position":1,"cik":"0001725018","reported_name":"Nazzi Gianfranco","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Growth Markets Commercial"}}],"security":"Restricted Share Units","published_at":"2018-03-06T21:18:42.000Z","date":"2018-03-03","kind":"exercise","acquired":false,"shares":1399,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Restricted share units were granted on March 3, 2017, with 1,399 vesting on each of March 3, 2018, March 3, 2019 and March 3, 2020 and 1,400 vesting on March 3, 2021."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Restricted share units were granted on March 3, 2017, with 1,399 vesting on each of March 3, 2018, March 3, 2019 and March 3, 2020 and 1,400 vesting on March 3, 2021."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":4198,"derivative":{"underlying":"Ordinary Shares","underlying_shares":1399},"source":{"system":"sec-edgar","filing":"0001209191-18-017227","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919118017227/doc4.xml","form_type":"4"}},{"id":4012721,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":141703,"kind":"person","name":"Nazzi Gianfranco","position":1,"cik":"0001725018","reported_name":"Nazzi Gianfranco","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Growth Markets Commercial"}}],"security":"Ordinary Shares","published_at":"2018-03-06T21:18:42.000Z","date":"2018-03-05","kind":"tax_withholding","acquired":false,"shares":732,"price":19.28,"value":14112.96,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":4912.357,"source":{"system":"sec-edgar","filing":"0001209191-18-017227","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919118017227/doc4.xml","form_type":"4"}},{"id":4012720,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":141703,"kind":"person","name":"Nazzi Gianfranco","position":1,"cik":"0001725018","reported_name":"Nazzi Gianfranco","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Growth Markets Commercial"}}],"security":"Ordinary Shares","published_at":"2018-03-06T21:18:42.000Z","date":"2018-03-03","kind":"exercise","acquired":true,"shares":1399,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."}],"balance_after":5644.357,"source":{"system":"sec-edgar","filing":"0001209191-18-017227","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919118017227/doc4.xml","form_type":"4"}},{"id":4067057,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":141703,"kind":"person","name":"Nazzi Gianfranco","position":1,"cik":"0001725018","reported_name":"Nazzi Gianfranco","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Growth Markets Commercial"}}],"security":"Restricted Share Units","published_at":"2018-02-12T21:23:00.000Z","date":"2018-02-09","kind":"grant","acquired":true,"shares":35823,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Restricted share units were granted on February 9, 2018, with 11,941 vesting on each of February 9, 2020, February 9, 2021 and February 9, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Restricted share units were granted on February 9, 2018, with 11,941 vesting on each of February 9, 2020, February 9, 2021 and February 9, 2022."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F2","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":35823,"derivative":{"underlying":"Ordinary Shares","underlying_shares":35823},"source":{"system":"sec-edgar","filing":"0001209191-18-009198","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919118009198/doc4.xml","form_type":"4"}},{"id":4067056,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":141703,"kind":"person","name":"Nazzi Gianfranco","position":1,"cik":"0001725018","reported_name":"Nazzi Gianfranco","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Growth Markets Commercial"}}],"security":"Stock Options (right to buy)","published_at":"2018-02-12T21:23:00.000Z","date":"2018-02-09","kind":"grant","acquired":true,"shares":91326,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Stock options were granted on February 9, 2018, with 30,442 vesting on each of February 9, 2020, February 9, 2021 and February 9, 2022."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F2","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":91326,"derivative":{"exercise_price":18.61,"expiration_date":"2028-02-08","underlying":"Ordinary Shares","underlying_shares":91326},"source":{"system":"sec-edgar","filing":"0001209191-18-009198","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919118009198/doc4.xml","form_type":"4"}}]}